GLP-1 users drive supplement boom, prompting safety concerns and calls for tighter oversight

Rising use of GLP-1 weight-loss drugs is reportedly driving demand for dietary supplements such as fibre, collagen, probiotics and electrolytes, as users seek to manage side effects including nausea, fatigue and constipation. The trend, amplified by social media influencers, has raised concerns over product safety, unverified health claims and limited pre-market scrutiny in the US. Regulators are considering tighter oversight of dietary ingredients. The trend highlights the need for stronger scrutiny of influencer-led health marketing, particularly for products targeting GLP-1 users.